Erythrocytes in nanomedicine: an optimal blend of natural and synthetic materials.

A hybrid approach strategy using synthetic nanoparticles and erythrocytes offers an optimal blend of natural and synthetic materials. The combined advantages of erythrocytes and nanoparticles could serve as an immune-evasive multifunctional platform. This review summarized the research on state-of-the-art and significant advances in erythrocytes for nanomedicine, and presented are their fabrication process, their unique properties and applications. According to its structure, this review mainly focuses on three kinds of erythrocyte-based nanomedicine: whole erythrocytes as carriers, cell membrane coated nanoparticles, and nanoerythrosomes. In addition, some future prospects are also prudentially addressed. We expect rapid success in the advancement of erythrocyte-based nanomedicines, from the bench to the bedside.

[1]  P. Poyet,et al.  Nanoerythrosome, a new derivative of erythrocyte ghost: preparation and antineoplastic potential as drug carrier for daunorubicin. , 1994, Anticancer research.

[2]  M. Hamidi,et al.  Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery. , 2007, International journal of pharmaceutics.

[3]  Feng Gao,et al.  Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. , 2014, ACS nano.

[4]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[5]  V. Kadam,et al.  Drug loaded erythrocytes: as novel drug delivery system. , 2008, Current pharmaceutical design.

[6]  M. Magnani,et al.  Erythrocyte-based drug delivery , 2005, Expert opinion on drug delivery.

[7]  Sang Joon Lee,et al.  Gold nanoparticle-incorporated human red blood cells (RBCs) for X-ray dynamic imaging. , 2011, Biomaterials.

[8]  T. Ishida,et al.  Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Dorota Bartczak,et al.  Preparation of peptide-functionalized gold nanoparticles using one pot EDC/sulfo-NHS coupling. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[10]  Ronnie H. Fang,et al.  'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. , 2013, Nanoscale.

[11]  Mary E Napier,et al.  The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. , 2010, Journal of the American Chemical Society.

[12]  Ronnie H. Fang,et al.  Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. , 2013, Nanoscale.

[13]  Dong Wang,et al.  Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. , 2015, ACS nano.

[14]  Tao Chen,et al.  One-step facile surface engineering of hydrophobic nanocrystals with designer molecular recognition. , 2012, Journal of the American Chemical Society.

[15]  Tohru Mizushima,et al.  Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles , 2009, Pharmaceutical Research.

[16]  Samir Mitragotri,et al.  Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Mehrdad Hamidi,et al.  Applications of carrier erythrocytes in delivery of biopharmaceuticals. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Samir Mitragotri,et al.  Red blood cell-mimicking synthetic biomaterial particles , 2009, Proceedings of the National Academy of Sciences.

[19]  Hans Bäumler,et al.  Surface-modified loaded human red blood cells for targeting and delivery of drugs , 2012, Journal of microencapsulation.

[20]  Helmuth Möhwald,et al.  Nanoplasmonics for dual-molecule release through nanopores in the membrane of red blood cells. , 2012, ACS nano.

[21]  Samir Mitragotri,et al.  Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. , 2010, Current pharmaceutical design.

[22]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[23]  Ronnie H. Fang,et al.  Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. , 2013, Nanomedicine.

[24]  S. Esener,et al.  Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. , 2010, Molecular pharmaceutics.

[25]  Y. Gho,et al.  Proteomics, transcriptomics and lipidomics of exosomes and ectosomes , 2013, Proteomics.

[26]  Yi Zhang,et al.  Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor. , 2015, Biomaterials.

[27]  M. Auger,et al.  Spectroscopic characterization of nanoErythrosomes in the absence and presence of conjugated polyethyleneglycols: an FTIR and (31)P-NMR study. , 2002, Biochimica et biophysica acta.

[28]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[29]  Mehrdad Hamidi,et al.  Carrier Erythrocytes: An Overview , 2003, Drug delivery.

[30]  Ronnie H. Fang,et al.  Nanoparticle-detained toxins for safe and effective vaccination , 2013, Nature nanotechnology.

[31]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[32]  Bo Zhang,et al.  Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery. , 2013, Journal of the American Chemical Society.

[33]  U. Schubert,et al.  Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.

[34]  R. Langer,et al.  Nanomedicine: developing smarter therapeutic and diagnostic modalities. , 2006, Advanced drug delivery reviews.

[35]  F. Ahsan,et al.  Nano-Engineered Erythrocyte Ghosts as Inhalational Carriers for Delivery of Fasudil: Preparation and Characterization , 2014, Pharmaceutical Research.

[36]  Ronnie H. Fang,et al.  Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. , 2013, Nanoscale.

[37]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[38]  Xue Shen,et al.  Polyetherimide-grafted Fe3O4@SiO2 nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging , 2015, International journal of nanomedicine.

[39]  Frank Caruso,et al.  Targeting of cancer cells using click-functionalized polymer capsules. , 2010, Journal of the American Chemical Society.

[40]  Fei Wang,et al.  Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers. , 2015, ACS nano.

[41]  Robert Franco,et al.  International seminar on the red blood cells as vehicles for drugs , 2012, Expert opinion on biological therapy.

[42]  A. Azadi,et al.  Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery. , 2011, Journal of pharmaceutical sciences.

[43]  U Teichgräber,et al.  Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. , 2006, Nano letters.

[44]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[45]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[46]  R. Schiffelers,et al.  Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Peisheng Xu,et al.  pH and redox dual responsive nanoparticle for nuclear targeted drug delivery. , 2012, Molecular pharmaceutics.

[48]  J. Agnihotri,et al.  Biodegradable long circulating cellular carrier for antimalarial drug pyrimethamine , 2013, Artificial cells, nanomedicine, and biotechnology.

[49]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[50]  V. Patravale,et al.  The upcoming field of theranostic nanomedicine: an overview. , 2012, Journal of biomedical nanotechnology.

[51]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[52]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[53]  Ronnie H. Fang,et al.  Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. , 2014, Nanoscale.

[54]  Samir Mitragotri,et al.  Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. , 2013, ACS nano.

[55]  Vladimir R Muzykantov,et al.  Drug delivery by red blood cells: vascular carriers designed by mother nature , 2010, Expert opinion on drug delivery.

[56]  B Gleich,et al.  Human erythrocytes as nanoparticle carriers for magnetic particle imaging , 2010, Physics in medicine and biology.

[57]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[58]  Dennis E Discher,et al.  Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels. , 2010, Blood cells, molecules & diseases.

[59]  Samir Mitragotri,et al.  Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation , 2007, Experimental biology and medicine.

[60]  E. Zocchi,et al.  Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin. , 1992, Advances in experimental medicine and biology.

[61]  S. Little,et al.  Biomimetic Delivery with Micro‐ and Nanoparticles , 2012, Advanced materials.

[62]  M. Hamidi,et al.  Preparation and Validation of Carrier Human Erythrocytes Loaded by Bovine Serum Albumin as a Model Antigen/Protein , 2007, Drug delivery.

[63]  Xingzhong Zhao,et al.  Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery. , 2014, ACS nano.

[64]  M. Hamidi,et al.  Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b. , 2007, International journal of pharmaceutics.

[65]  Zheng Wang,et al.  Noninvasive theranostic imaging of HSV-TK/GCV suicide gene therapy in liver cancer by folate-targeted quantum dot-based liposomes. , 2015, Biomaterials science.

[66]  A. Zanella,et al.  Erythrocyte engineering for drug delivery and targeting , 1998, Biotechnology and applied biochemistry.

[67]  M. Magnani,et al.  Erythrocytes as a novel delivery vehicle for biologics: from enzymes to nucleic acid-based therapeutics. , 2012, Therapeutic delivery.

[68]  C. Ménager,et al.  Human Erythrocytes Covered with Magnetic Core–Shell Nanoparticles for Multimodal Imaging , 2013, Advanced healthcare materials.

[69]  C. Ménager,et al.  Red blood cells decorated with functionalized core-shell magnetic nanoparticles: elucidation of the adsorption mechanism. , 2013, Chemical communications.

[70]  Xin Yu Wang,et al.  Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[71]  M. Rouini,et al.  In Vitro Characterization of Human Intact Erythrocytes Loaded by Enalaprilat , 2001, Drug delivery.

[72]  W. Grizzle,et al.  Exosomes are endogenous nanoparticles that can deliver biological information between cells. , 2013, Advanced drug delivery reviews.

[73]  Ronnie H. Fang,et al.  Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes , 2013, Advanced materials.

[74]  Helmuth Möhwald,et al.  Red blood cells and polyelectrolyte multilayer capsules: natural carriers versus polymer-based drug delivery vehicles , 2013, Expert opinion on drug delivery.

[75]  Volker Wagner,et al.  The emerging nanomedicine landscape , 2006, Nature Biotechnology.